USANA Health Sciences, Inc.: dividend

USNANYSEBasic materials · Medicinal Chemicals & Botanical Products

Price

$13.24

November 13, 2026Market cap $244M

What Ploutos Investor adds for USANA Health Sciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

USANA Health Sciences pays no dividend

It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 11.26% of market cap in the latest fiscal year.

All dividend stocks

Everything it returns to shareholders

The dividend is one way. The other is buybacks, which reduce the number of shares.

Dividend yield

0.00%

Buybacks

11.26%

$112.60 a year per $1,000 of shares

The share count fell by 2.4% over the year.

Total returned

11.26%

$112.60 a year per $1,000 of shares

dividend 0%buybacks 100%

The full analysis

What do USANA Health Sciences's filings show?

The dividend is one part of USANA Health Sciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about USNA's dividend

Didn't find what you were looking for?

Ask us
Does USNA pay a dividend?

It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 11.26% of market cap in the latest fiscal year.

How does USNA return money to shareholders?

USANA Health Sciences pays no dividend. Its buybacks in the latest fiscal year came to 11.26% of market cap.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.